SwePub
Sök i LIBRIS databas

  Utökad sökning

L773:1010 4283
 

Sökning: L773:1010 4283 > Upregulation of the...

Upregulation of the antiapoptotic factor Livin contributes to cisplatin resistance in colon cancer cells

Ding, Zhen-Yu (författare)
Linköpings universitet,Institutionen för klinisk och experimentell medicin,Hälsouniversitetet
Liu, Gui-Hong (författare)
Sichuan University, China
Olsson, Birgit (författare)
Linköpings universitet,Onkologi,Hälsouniversitetet
visa fler...
Sun, Xiao-Feng (författare)
Östergötlands Läns Landsting,Linköpings universitet,Avdelningen för kliniska vetenskaper,Hälsouniversitetet,Onkologiska kliniken US
visa färre...
 (creator_code:org_t)
2012-11-28
2013
Engelska.
Ingår i: Tumor Biology. - : Karger / Springer Verlag (Germany). - 1010-4283 .- 1423-0380. ; 34:2, s. 683-693
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • The antiapoptotic factor Livin has been considered critical for tumor progression and poor prognosis for variant types of tumors. However, there are only limited reports regarding its expression and biological functions in colon cancer. Here, we examined Livin expression in four colon cancer cell lines (HCT116, RKO, KM12C, and SW620) in the presence or absence of cisplatin that was used as a model reagent. We found the different response to cisplatin was related to endogenous Livin expression level. From among a panel of apoptosis-related factors (p53, Bcl-2, Bcl-XL, BAX, and survivin), the expression of Livin was upregulated after cisplatin treatment in a dose-dependent manner. Both immunocytochemistry and nuclear cytoplasmic fractionation indicated Livin remained in the cytoplasm after treatment with cisplatin. In an attempt to explore the mechanism, we found the elevated expression of Livin was not due to the decreased degradation by proteosome but was enhanced at the mRNA level. Besides, cisplatin treatment activated the mammalian target of rapamycin (mTOR) pathway as shown by increased phosphorylation of Akt1, mTOR, S6K, and 4E-BP1, together with the elevated Livin. The PI3K inhibitor LY294002 inhibited both the phosphorylation of mTOR and upregulation of Livin. The stable overexpression of Livin inhibited the activation of caspase-3 and led to resistance to cisplatin, while the knockdown of Livin by siRNA rendered colon cancer cells more sensitive to cisplatin. Our study, along with others, highlighted the potential of Livin for cancer therapy in colon cancer.

Nyckelord

Livin; Apoptosis; Cisplatin; Colon cancer
MEDICINE
MEDICIN

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...
Ding, Zhen-Yu
Liu, Gui-Hong
Olsson, Birgit
Sun, Xiao-Feng
Artiklar i publikationen
Tumor Biology
Av lärosätet
Linköpings universitet

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy